GELS: Gelteq Limited Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 21.24
Enterprise Value ($M) 21.24
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.14
Operating Income -2.61
Net Income -3.55

Cash Flow Statement (mra) ($M)
Cash From Operations -1.07
Cash from Investing -0.15
Cash from Financing 0.84

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-03 4,929 132,955 3.71
2025-01-31 9,029 85,928 10.51
2025-01-30 35,205 218,967 16.08
2025-01-29 4,124 31,648 13.03

(click for more detail)

Similar Companies
FTLF – FitLife Brands, Inc. GALT – Galectin Therapeutics Inc.
GDTC – CytoMed Therapeutics Limited GLMD – Galmed Pharmaceuticals Ltd.
GLSI – Greenwich LifeSciences, Inc.


Financial data and stock pages provided by
Fintel.io